Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 6451561
[patent_doc_number] => 20020177619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Steroid sulphatase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/082007
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 4807
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082007
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082007 | Steroid sulphatase inhibitors | Feb 20, 2002 | Issued |
Array
(
[id] => 5845460
[patent_doc_number] => 20020132846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans'
[patent_app_type] => new
[patent_app_number] => 10/081516
[patent_app_country] => US
[patent_app_date] => 2002-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 816
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081516 | Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans | Feb 20, 2002 | Abandoned |
Array
(
[id] => 6381910
[patent_doc_number] => 20020120002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Use of melatonin analogues for induction of general anesthesia'
[patent_app_type] => new
[patent_app_number] => 10/078643
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3911
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20020120002.pdf
[firstpage_image] =>[orig_patent_app_number] => 10078643
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/078643 | Use of melatonin analogues for induction of general anesthesia | Feb 18, 2002 | Issued |
Array
(
[id] => 6159124
[patent_doc_number] => 20020147220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods for treating apnea and apnea disorders using optically pure (+) norcisapride'
[patent_app_type] => new
[patent_app_number] => 10/075617
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7791
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075617 | Methods for treating sleep apnea and sleep induced apnea using optically pure () norcisapride | Feb 14, 2002 | Issued |
09/926404 | INJECTABLE PHARMACEUTICAL SOLUTION COMPRISING DX9065a | Feb 13, 2002 | Abandoned |
Array
(
[id] => 5987622
[patent_doc_number] => 20020099082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Use of glucose uptake enhancer for reducing apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/072098
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5093
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10072098
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/072098 | Use of glucose uptake enhancer for reducing apoptosis | Feb 6, 2002 | Abandoned |
Array
(
[id] => 5969051
[patent_doc_number] => 20020091103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder'
[patent_app_type] => new
[patent_app_number] => 10/068035
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3222
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068035 | Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder | Feb 4, 2002 | Abandoned |
Array
(
[id] => 6159107
[patent_doc_number] => 20020147214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Heterocyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/062647
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35658
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062647
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062647 | Heterocyclic compounds | Jan 30, 2002 | Issued |
Array
(
[id] => 1356166
[patent_doc_number] => 06576646
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-10
[patent_title] => 'Methods for treating cognitive impairments caused by traumatic brain injuries'
[patent_app_type] => B1
[patent_app_number] => 10/054931
[patent_app_country] => US
[patent_app_date] => 2002-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4995
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/576/06576646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054931 | Methods for treating cognitive impairments caused by traumatic brain injuries | Jan 24, 2002 | Issued |
Array
(
[id] => 6788229
[patent_doc_number] => 20030139468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Amiodarone solutions suitable for intravenous administration'
[patent_app_type] => new
[patent_app_number] => 10/054493
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2199
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20030139468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054493 | Amiodarone solutions suitable for intravenous administration | Jan 21, 2002 | Abandoned |
Array
(
[id] => 5936634
[patent_doc_number] => 20020061867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Prevention of ovarian cancer by administration of a Vitamin D compound'
[patent_app_type] => new
[patent_app_number] => 10/051662
[patent_app_country] => US
[patent_app_date] => 2002-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7536
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10051662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/051662 | Prevention of ovarian cancer by administration of a Vitamin D compound | Jan 17, 2002 | Issued |
Array
(
[id] => 6847561
[patent_doc_number] => 20030166728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/047802
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9937
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10047802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/047802 | Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer | Jan 15, 2002 | Issued |
Array
(
[id] => 6278618
[patent_doc_number] => 20020107225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Methods of treating leukemia'
[patent_app_type] => new
[patent_app_number] => 10/046289
[patent_app_country] => US
[patent_app_date] => 2002-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5042
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10046289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/046289 | Methods of treating leukemia | Jan 15, 2002 | Issued |
09/926286 | Use of alpha lipoic acid in the antimetastatic treatment | Jan 14, 2002 | Abandoned |
Array
(
[id] => 5987435
[patent_doc_number] => 20020099044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Composition comprising amoxycillin and clavulanic acid'
[patent_app_type] => new
[patent_app_number] => 10/043437
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2721
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10043437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/043437 | Composition comprising amoxycillin and clavulanic acid | Jan 10, 2002 | Abandoned |
Array
(
[id] => 1389475
[patent_doc_number] => 06548550
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field'
[patent_app_type] => B1
[patent_app_number] => 10/030060
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2272
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548550.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030060
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030060 | Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field | Jan 3, 2002 | Issued |
Array
(
[id] => 6736129
[patent_doc_number] => 20030013764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Use for a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs'
[patent_app_type] => new
[patent_app_number] => 10/024476
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4493
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024476 | Use for a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs | Dec 20, 2001 | Abandoned |
Array
(
[id] => 6721382
[patent_doc_number] => 20030055072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Methods of inhibiting Pin1-associated states using a fredericamycin a compound'
[patent_app_type] => new
[patent_app_number] => 10/027864
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15149
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055072.pdf
[firstpage_image] =>[orig_patent_app_number] => 10027864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/027864 | Methods of inhibiting Pin1-associated states using a fredericamycin a compound | Dec 20, 2001 | Abandoned |
Array
(
[id] => 1531190
[patent_doc_number] => 06488164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-03
[patent_title] => 'Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue'
[patent_app_type] => B2
[patent_app_number] => 10/029306
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5484
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/488/06488164.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029306
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029306 | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue | Dec 19, 2001 | Issued |
Array
(
[id] => 7622233
[patent_doc_number] => 06977268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-20
[patent_title] => 'Methods and compositions for inhibition of angiogenesis with EM-138'
[patent_app_type] => utility
[patent_app_number] => 10/026037
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 6909
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/977/06977268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026037 | Methods and compositions for inhibition of angiogenesis with EM-138 | Dec 18, 2001 | Issued |